Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Zuin

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Annals of Surgical Oncology|September 4, 2009
Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosisRoberto Santambrogio, Enrico Opocher, Massimo Zuin, et al.
Gerontology|June 19, 2008
Late-onset autoimmunity: the paradigm of primary biliary cirrhosis--a mini-reviewSamuel M Siegel, Carlo Selmi, Lorenzo Dottorini, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 19, 2003
T-cell receptor polymorphism in primary biliary cirrhosisCarlo Selmi, Pietro Invernizzi, Pasquale Tripputi, et al.
Annals of Surgical Oncology|July 7, 2011
Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoproteinRoberto Santambrogio, Enrico Opocher, Mara Costa, et al.
Surgical Endoscopy|November 3, 2011
Recurrent hepatocellular carcinoma successfully treated with laparoscopic thermal ablationRoberto Santambrogio, Mara Costa, Matteo Barabino, et al.
Medical Oncology (Northwood, London, England)|March 21, 2020
Laparoscopic thermoablation for hepatocellular carcinoma in patients with liver cirrhosis: an effective procedure for tricky tumorsRoberto Santambrogio, Matteo Barabino, Valentina D'Alessandro, et al.
Pharmacological Research|October 26, 2018
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)Francesco Bifari, Roberto Manfrini, Michele Dei Cas, et al.
Journal of Clinical Gastroenterology|January 29, 2008
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal studyAlberto Benetti, Andrea Crosignani, Massimo Varenna, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Liver toxicity in the era of immune checkpoint inhibitors: A practical approachCarmen Belli, Massimo Zuin, Luca Mazzarella, et al.
Surgical Endoscopy|August 16, 2015
Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patientsRoberto Santambrogio, Matteo Barabino, Savino Bruno, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|September 4, 2009
Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosisRoberto Santambrogio, Enrico Opocher, Massimo Zuin, et al.
Gerontology|June 19, 2008
Late-onset autoimmunity: the paradigm of primary biliary cirrhosis--a mini-reviewSamuel M Siegel, Carlo Selmi, Lorenzo Dottorini, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 19, 2003
T-cell receptor polymorphism in primary biliary cirrhosisCarlo Selmi, Pietro Invernizzi, Pasquale Tripputi, et al.
Annals of Surgical Oncology|July 7, 2011
Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoproteinRoberto Santambrogio, Enrico Opocher, Mara Costa, et al.
Surgical Endoscopy|November 3, 2011
Recurrent hepatocellular carcinoma successfully treated with laparoscopic thermal ablationRoberto Santambrogio, Mara Costa, Matteo Barabino, et al.
Medical Oncology (Northwood, London, England)|March 21, 2020
Laparoscopic thermoablation for hepatocellular carcinoma in patients with liver cirrhosis: an effective procedure for tricky tumorsRoberto Santambrogio, Matteo Barabino, Valentina D'Alessandro, et al.
Pharmacological Research|October 26, 2018
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)Francesco Bifari, Roberto Manfrini, Michele Dei Cas, et al.
Journal of Clinical Gastroenterology|January 29, 2008
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal studyAlberto Benetti, Andrea Crosignani, Massimo Varenna, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Liver toxicity in the era of immune checkpoint inhibitors: A practical approachCarmen Belli, Massimo Zuin, Luca Mazzarella, et al.
Surgical Endoscopy|August 16, 2015
Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patientsRoberto Santambrogio, Matteo Barabino, Savino Bruno, et al.
Pageof 8